Jason Witherington
Greater London, England, United Kingdom
2K followers
500+ connections
About
I have over 25 years as a senior leader within the Life Science sector and I have a…
Activity
-
This past weekend, our team at Johnson & Johnson Innovative Medicine presented important data at #UEGW2024. The insightful discussions we had will be…
This past weekend, our team at Johnson & Johnson Innovative Medicine presented important data at #UEGW2024. The insightful discussions we had will be…
Liked by Jason Witherington
-
We are excited to announce that we have entered into a collaboration with MSD, which deploys Mestag’s proprietary RAFT platform to interrogate the…
We are excited to announce that we have entered into a collaboration with MSD, which deploys Mestag’s proprietary RAFT platform to interrogate the…
Liked by Jason Witherington
-
📢 Exciting news! Citryll is collaborating with leading rheumatology centres in the Netherlands on a groundbreaking project funded by ReumaNederland…
📢 Exciting news! Citryll is collaborating with leading rheumatology centres in the Netherlands on a groundbreaking project funded by ReumaNederland…
Liked by Jason Witherington
Experience
Education
-
University of Pennsylvania
-
Post-doctoral studies under the guidance of Professors Amos B. Smith III, Ralph Hirschmann and Stephen Benkovic
Publications
-
Human-relevant near-organ neuromodulation of the immune system via the splenic nerve
Proceedings of the National Academy of Sciences of the United States of America
-
Quantification of clinically applicable stimulation parameters for precision near-organ neuromodulation of human splenic nerves
Communications biology
-
Effect of Superior Ovarian Nerve and Plexus Nerve Sympathetic Denervation on Ovarian-Derived Infertility Provoked by Estradiol Exposure to Rats
Frontiers in physiology
-
Structure-based design of an N-terminal bromodomain selective bromodomain and extraterminal (BET) inhibitor retaining an antiproliferative phenotype
Abstracts of Papers, 258th ACS National Meeting & Exposition, San Diego, CA, United States, August 25-29, 2019
-
BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo
Antiviral Research
-
Neuronal control of experimental colitis occurs via sympathetic intestinal innervation
Neurogastroenterology & Motility
-
Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses
Journal of Medicinal Chemistry
-
avigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 Agonists
Journal of Medicinal Chemistry
-
avigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 Agonists
Journal of Medicinal Chemistry
-
BET Inhibition As A Potential Therapy For Human Papillomavirus Infection
Antimicrobial Agents and Chemotherapy
-
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
J. Med. Chem
-
Inhibition of Osteoclastogenesis and Inflammatory Bone Resorption by Targeting BET proteins and Epigenetic Regulation
Nature Medicine.
-
Naphthyridines as Novel BET Family Bromodomain Inhibitors
ChemMedChem
-
Optimization of S1P1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles
J. Med. Chem
-
The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes
MedChemComm
-
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762
Blood
-
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists
Bioorg. Med. Chem. Lett
-
Selective inhibition of CD4+ T-cell cytokine production and autoimmunity BET protein and c-Myc inhibitors
PNAS
-
The discovery of the benzazepine class of histamine H3 receptor antagonists
Bioorg. Med. Chem. Lett
-
Application of chemoproteomics for the discovery of a new druggable epigenetic target class and potential therapeutic utility
Abstracts of Papers, 244th ACS
-
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151(GSK1210151A)
Bioorg. Med. Chem. Lett
-
Place your BETs: the therapeutic potential of bromodomains
Trends in Pharmacological Sciences
-
The utility of pharmacokinetic-pharmacodynamic modeling in the discovery and optimization of selective S1P1 agonists
Xenobiotica
-
− Discovery of a Brain-Penetrant S1P3-Sparing Direct Agonist of the S1P1 and S1P5 Receptors Efficacious at Low Oral Dose
J. Med. Chem
-
Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart Rate
ACS Med. Chem. Lett
-
Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions
J. Biomol. Screening
-
Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor
Bioorg. Med. Chem. Lett
-
Functional and in situ hybridization evidence that preganglionic sympathetic vasoconstrictor neurons express ghrelin receptors
Neuroscience
-
Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain
Bioorg. Med. Chem. Lett
-
5-hydroxyindalpine, an agonist at the putative 5-HT1P receptor, has no activity on human recombinant monoamine receptors but accelerates distension-induced peristalsis in mouse isolated colon
Neurogastroenterology & Motility
-
Cognitive enhancing effects of ghrelin receptor agonists
Psychopharmacology
-
Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation
Neurogastroenterology & Motility
-
Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimization
Bioorg. Med. Chem. Lett
-
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
J. Pharm. & Exp. Ther
-
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification
Bioorg. Med. Chem. Lett
-
Therapeutic approaches towards the treatment of gastrointestinal disorders
Drug News & Perspectives
-
3-Amino pyrazoles as potent and selective glycogen kinase synthase 3 (GSK-3) inhibitors
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors, Wiley
-
A new asymmetric synthesis of (+)-12b-epidevinylantirhine
Tet. Lett
-
Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin
Neuroscience Lett
-
Complementary stereoselective conjugate addition reactions on indolo[2,3-a]quinolizine templates
Tet. Lett
-
Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat
J. Physiology
-
Organolithium-Induced Alkylative Ring Opening of Aziridines: Synthesis of Unsaturated Amino Alcohols and Ethers
J. Org. Chem
-
Pyridone derivatives as potent and selective VLA-4 integrin antagonists
Bioorg. Med. Chem. Lett
-
Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists
Bioorg. Med. Chem. Lett
-
Recent disclosures of clinical drug candidates
Drug news & perspectives
-
− (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors
Bioorg. Med. Chem. Lett
-
Challenges facing drug discovery in vascular disease
Drug news & perspectives
-
Organolithium-induced enantioselective alkylative double ring-opening of epoxides: synthesis of enantioenriched unsaturated amino alcohols
Tetrahedron.
-
Unsaturated 1,2-amino alcohols and ethers aziridines and organolithiums
Chem. Comm
-
5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Bioorg. Med. Chem. Lett.
-
5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Bioorg. Med. Chem. Lett.
-
6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
Bioorg. Med. Chem. Lett.
-
6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
Bioorg. Med. Chem. Lett
-
CCR2: Characterization of the Antagonist Binding Site a Combined Receptor Modeling/Mutagenesis Approach
J. Med. Chem.
-
Enantioselective alkylative double ring opening of epoxides: Synthesis of enantioenriched unsaturated diols and amino alcohols
Angewandte Chemie, International Edition
-
Unsaturated 1,2-amino alcohols dihydropyrrole epoxides and organolithiums
Synlett
-
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists
Bioorg. Med. Chem. Lett.
-
Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K
J. Med. Chem.
-
Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin K
Bioorg. Med. Chem. Lett
-
Solid-phase synthesis of cyclic alkoxyketones, inhibitors of the cysteine protease cathepsin K
Bioorg. Med. Chem. Lett.
-
Orally bioavailable inhibitors of the cysteine protease cathepsin K
218th ACS National Meeting
-
Isomerizations of cycloalkene- and bicycloalkene-derived achiral epoxides enantioselective deprotonation
Journal of the Chemical Society, Perkin Transactions 1: Org. & Bioorg. Chem
-
Investigations of an Antibody Ligase
J. Am. Chem. Soc
-
Phosphonate Diester and Phosphonamide Synthesis. Reaction Coordinate Analysis 31P NMR Spectroscopy: Identification of Pyrophosphonate Anhydrides and Highly Reactive Phosphonylammonium Salts
J. Am. Chem. Soc
-
Pd/Cu Co-catalyzed cross-coupling reactions of methyl (Z)-2-tributylstannyl-3-methoxypropenoate: a method for direct introduction of the agrochemically important beta-methoxyacrylate toxophore
Synlett
-
Phosphonyltriethylammonium Salts: Novel Reactive Species for the Synthesis of Phosphonate Esters and Phosphonamides
J. Am. Chem. Soc.
-
Concise racemic and highly enantioselective approaches to key intermediates for the syntheses of carbocyclic nucleosides and pseudo-ribofuranoses: formal syntheses of carbovir
J. Chem. Soc., Perkin Transactions 1: Org. and Bio-Org. Chem
-
Regio- and stereospecific synthesis of cis-(±)-1-acetoxy-4-(acetoxymethyl)cyclopent-2-ene: a key intermediate in the synthesis of carbocyclic nucleosides and pseudo-ribofuranoses
Org. and Bio-Org. Chem
-
Human-relevant near-organ neuromodulation of the immune system via the splenic nerve
Proceedings of the National Academy of Sciences of the United States of America
More activity by Jason
-
Yesterday we announced the candidate nomination of our lead program targeting the melanocortin-2 (MC2) receptor, a GPCR for the adrenocorticotropic…
Yesterday we announced the candidate nomination of our lead program targeting the melanocortin-2 (MC2) receptor, a GPCR for the adrenocorticotropic…
Liked by Jason Witherington
-
Delighted to share my latest article in Nature Magazine (Nature Reviews Drug Discovery), contrasting the life science innovation in China and…
Delighted to share my latest article in Nature Magazine (Nature Reviews Drug Discovery), contrasting the life science innovation in China and…
Liked by Jason Witherington
-
Really excited to have the opportunity to lead such a great team and deliver on the therapeutic potential of our innovative platform. Thanks to…
Really excited to have the opportunity to lead such a great team and deliver on the therapeutic potential of our innovative platform. Thanks to…
Liked by Jason Witherington
-
And that's a wrap! After nearly 33 years at Glaxo/GlaxoWellcome/GSK, it's time for me to slow down a little (perhaps!) and try some new experiences…
And that's a wrap! After nearly 33 years at Glaxo/GlaxoWellcome/GSK, it's time for me to slow down a little (perhaps!) and try some new experiences…
Liked by Jason Witherington
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Jason Witherington
1 other named Jason Witherington is on LinkedIn
See others named Jason Witherington